Table 6.
Univariate analysis investigating the impact of neoadjuvant therapy radiochemotherapy on the response
|
|
OR
|
95%CI
|
P
value
|
| Radiological response | |||
| Disease progression | Reference | ||
| Stable disease | 4 | 0.39-40.42 | 0.240 |
| Partial response | 12.5 | 1.21-128.61 | 0.035 |
| Complete response | NA1 | ||
| Pathological tumor response | |||
| 0%-10% | Reference | ||
| 11%-30% | 0.474 | 0.05-3.92 | 0.489 |
| 31%-50% | 0.14 | 0.17-1.13 | 0.065 |
| 51%-70% | 0.03 | 0.004-0.30 | 0.002 |
| > 70% | 0.01 | 0.001-0.16 | 0.001 |
| Pathological nodal response | |||
| 0%-10% | Reference | ||
| 11%-30% | 0.474 | 0.057-3.92 | 0.489 |
| 31%-50% | 0.14 | 0.17-0.13 | 0.065 |
| 51%-70% | 0.03 | 0.004-0.30 | 0.002 |
| > 70% | 0.01 | 0.001-0.16 | 0.001 |
| Downstaging | |||
| No | Reference | ||
| Yes | 8 | 2.34-27.32 | 0.001 |
Not applicable: only one patient in the chemoradiotherapy group and none in the Chemotherapy group. CI: Confidence interval.